tiprankstipranks
Trending News
More News >
Xylo Technologies Ltd. Sponsored Adr (XYLO)
:XYLO
Advertisement

Xylo Technologies Ltd (XYLO) Price & Analysis

Compare
270 Followers

XYLO Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.03%2.03%97.97%
Insiders
2.03% Other Institutional Investors
97.97% Public Companies and
Individual Investors

XYLO FAQ

What was Xylo Technologies Ltd. Sponsored Adr’s price range in the past 12 months?
Xylo Technologies Ltd. Sponsored Adr lowest stock price was $2.70 and its highest was $6.75 in the past 12 months.
    What is Xylo Technologies Ltd. Sponsored Adr’s market cap?
    Xylo Technologies Ltd. Sponsored Adr’s market cap is $4.16M.
      When is Xylo Technologies Ltd. Sponsored Adr’s upcoming earnings report date?
      Xylo Technologies Ltd. Sponsored Adr’s upcoming earnings report date is Sep 08, 2025 which is in 49 days.
        How were Xylo Technologies Ltd. Sponsored Adr’s earnings last quarter?
        Currently, no data Available
        Is Xylo Technologies Ltd. Sponsored Adr overvalued?
        According to Wall Street analysts Xylo Technologies Ltd. Sponsored Adr’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Xylo Technologies Ltd. Sponsored Adr pay dividends?
          Xylo Technologies Ltd. Sponsored Adr pays a Notavailable dividend of $2.267 which represents an annual dividend yield of N/A. See more information on Xylo Technologies Ltd. Sponsored Adr dividends here
            What is Xylo Technologies Ltd. Sponsored Adr’s EPS estimate?
            Xylo Technologies Ltd. Sponsored Adr’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Xylo Technologies Ltd. Sponsored Adr have?
            Xylo Technologies Ltd. Sponsored Adr has 1,281,042 shares outstanding.
              What happened to Xylo Technologies Ltd. Sponsored Adr’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Xylo Technologies Ltd. Sponsored Adr?
              Currently, no hedge funds are holding shares in XYLO

              Company Description

              Xylo Technologies Ltd. Sponsored Adr

              Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
              Similar Stocks
              Company
              Price & Change
              Follow
              Nuwellis
              Sintx Technologies
              ReShape Lifesciences
              Venus Concept
              Heart Test Laboratories, Inc.
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis